CN Stock MarketDetailed Quotes
603079 Zhejiang Shengda Bio-Pharm
- 15.02
- -0.26-1.70%
Not Open Nov 28 15:00 CST
2.57BMarket Cap-89404P/E (TTM)
15.28High14.85Low120.05KlotVolume15.28Open15.28Pre Close180.47MTurnover7.01%Turnover RatioLossP/E (Static)171.19MShares21.2152wk High2.05P/B2.57BFloat Cap6.9552wk Low16.81Limit Up171.19MShs Float43.21Historical High13.75Limit Down2.81%Amplitude6.95Historical Low0.06Dividend TTM15.03Avg Price62.29KlotAsk0.40%Div YieldTTM100Lot Size54.04KlotBid
Zhejiang Shengda Bio-Pharm Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 9.36%601.48M | 3.48%361.74M | 6.72%178.97M | -7.81%701.27M | -2.70%550.02M | -5.83%349.55M | 1.93%167.69M | -4.53%760.7M | -1.88%565.25M | -3.54%371.2M |
| Refunds of taxes and levies | -18.41%18.08M | -28.48%12.09M | 9.91%6.83M | -37.22%27.99M | -42.00%22.16M | -44.90%16.91M | -48.85%6.21M | 35.72%44.58M | 49.91%38.21M | 85.34%30.69M |
| Cash received relating to other operating activities | -43.26%10.76M | 9.63%12.11M | -24.70%4.77M | -39.74%16.66M | -29.40%18.97M | -20.89%11.05M | -26.17%6.33M | 23.22%27.64M | 14.06%26.87M | -7.82%13.96M |
| Cash inflows from operating activities | 6.63%630.32M | 2.23%385.94M | 5.73%190.56M | -10.45%745.92M | -6.22%591.15M | -9.22%377.51M | -2.70%180.24M | -2.25%832.93M | 0.83%630.33M | -0.16%415.85M |
| Goods services cash paid | -4.31%389.2M | -7.34%258.74M | -26.03%122.36M | -20.25%484.16M | -7.92%406.73M | -2.02%279.25M | 26.21%165.41M | 13.26%607.08M | 25.23%441.7M | 29.74%285M |
| Staff behalf paid | 3.95%105.09M | -4.84%73.31M | -9.31%43.63M | 0.09%125.34M | 4.14%101.1M | 9.54%77.04M | 2.93%48.1M | 3.08%125.23M | 10.13%97.08M | 9.49%70.33M |
| All taxes paid | -15.67%25.96M | -21.16%17.1M | 57.10%13M | 21.71%37.96M | 31.67%30.79M | 43.80%21.69M | 16.28%8.27M | -28.10%31.19M | -46.05%23.38M | -47.11%15.08M |
| Cash paid relating to other operating activities | -22.53%28.79M | 10.35%25.17M | 135.38%19.36M | 18.52%34.04M | 33.78%37.16M | 34.44%22.81M | -29.45%8.23M | -62.58%28.73M | -57.04%27.78M | -67.32%16.96M |
| Cash outflows from operating activities | -4.64%549.05M | -6.60%374.32M | -13.77%198.35M | -13.98%681.5M | -2.40%575.78M | 3.46%400.78M | 17.01%230.01M | 1.88%792.21M | 7.48%589.94M | 6.33%387.38M |
| Net cash flows from operating activities | 429.00%81.27M | 149.94%11.62M | 84.36%-7.79M | 58.22%64.42M | -61.97%15.36M | -181.72%-23.27M | -339.12%-49.78M | -45.32%40.72M | -47.04%40.4M | -45.44%28.48M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 377.27%105M | 225.00%65M | --22M | -90.59%32M | -92.59%22M | -71.43%20M | ---- | 6.92%340M | 2.41%297M | -68.89%70M |
| Cash received from returns on investments | 190.10%3.02M | 295.69%2.93M | 478.81%1.69M | -99.49%58.14K | -89.92%1.04M | -90.28%740.46K | -63.77%292.19K | -47.19%11.39M | -28.80%10.31M | -22.28%7.62M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -65.61%184.27K | -85.99%28.47K | -4.10%25.89K | 36.97%730.13K | 453.33%535.82K | 165.66%203.26K | -64.00%27K | -42.91%533.05K | -9.14%96.84K | -28.21%76.51K |
| Cash inflows from investing activities | 358.95%108.2M | 224.48%67.96M | 7,330.31%23.72M | -90.68%32.79M | -92.33%23.58M | -73.04%20.94M | -99.11%319.19K | 3.35%351.93M | 0.93%307.41M | -66.93%77.69M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -19.63%132.52M | 2.00%91.52M | -2.62%46.29M | 288.76%245.93M | 309.67%164.88M | 211.64%89.72M | 202.52%47.53M | -36.72%63.26M | -22.46%40.25M | -13.60%28.79M |
| Cash paid to acquire investments | 3,725.73%191.29M | 740.00%42M | 520.00%62M | -93.24%25M | -98.67%5M | -98.00%5M | -95.07%10M | 55.46%370M | -7.15%377M | -32.62%250M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | -59.03%2.87M | --2.72M | ---- | ---- | --7M | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --512K | --897.06K | --897.06K | --512K | ---- | ---- | ---- |
| Cash outflows from investing activities | 86.64%323.8M | 39.64%133.52M | 86.56%108.29M | -37.69%274.31M | -58.42%173.49M | -65.70%95.62M | -73.46%58.04M | 30.27%440.26M | -8.89%417.25M | -31.06%278.79M |
| Net cash flows from investing activities | -43.81%-215.6M | 12.21%-65.56M | -46.51%-84.57M | -173.42%-241.52M | -36.49%-149.92M | 62.87%-74.67M | 68.43%-57.72M | -3,569.83%-88.33M | 28.38%-109.84M | -18.67%-201.1M |
| Financing cash flow | ||||||||||
| Cash from borrowing | -25.84%132M | -37.01%80M | 19.75%57M | 157.10%237.9M | 92.36%178M | 103.09%127M | -9.39%47.6M | -74.15%92.53M | -68.68%92.53M | -75.80%62.53M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.4M | ---- | ---- |
| Cash inflows from financing activities | -25.84%132M | -37.01%80M | 19.75%57M | 150.60%237.9M | 92.36%178M | 103.09%127M | -9.39%47.6M | -73.48%94.93M | -68.68%92.53M | -75.80%62.53M |
| Borrowing repayment | 334.01%130.2M | 213.00%93.9M | -66.67%10M | -85.18%32.4M | -85.26%30M | -71.85%30M | -40.00%30M | -30.53%218.58M | -22.92%203.58M | -36.58%106.58M |
| Dividend interest payment | 38.34%16.26M | 29.46%14.54M | 15.45%454.78K | -48.28%14.19M | -57.84%11.75M | -58.42%11.23M | -78.31%393.93K | -58.10%27.43M | -56.64%27.87M | -56.99%27.01M |
| Cash payments relating to other financing activities | 97.40%13.95M | 148.83%13.51M | --13.11M | 147.02%14.33M | 53.02%7.07M | 17.62%5.43M | ---- | 1,008.91%5.8M | --4.62M | --4.62M |
| Cash outflows from financing activities | 228.59%160.41M | 161.35%121.95M | -22.45%23.57M | -75.81%60.92M | -79.32%48.82M | -66.24%46.66M | -41.34%30.39M | -33.84%251.81M | -28.11%236.07M | -40.13%138.21M |
| Net cash flows from financing activities | -121.99%-28.41M | -152.22%-41.95M | 94.30%33.43M | 212.81%176.98M | 190.00%129.18M | 206.15%80.34M | 2,302.80%17.21M | -590.54%-156.88M | -335.66%-143.53M | -374.44%-75.68M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -0.87%2.42M | 157.64%2.89M | 184.78%334.42K | -85.25%2.63M | -86.77%2.44M | -89.88%1.12M | -18.31%-394.45K | 367.25%17.83M | 620.65%18.46M | 369.38%11.08M |
| Net increase in cash and cash equivalents | -5,369.37%-160.32M | -464.10%-93M | 35.39%-58.59M | 101.35%2.51M | 98.49%-2.93M | 93.05%-16.49M | 53.20%-90.69M | -492.01%-186.67M | -71.28%-194.52M | -152.87%-237.21M |
| Add:Begin period cash and cash equivalents | 0.83%305.87M | 0.83%305.87M | -12.79%305.87M | -38.09%303.36M | -38.09%303.36M | -38.09%303.36M | -28.43%350.72M | 10.76%490.02M | 10.76%490.02M | 10.76%490.02M |
| End period cash equivalent | -51.55%145.55M | -25.80%212.87M | -4.90%247.28M | 0.83%305.87M | 1.66%300.42M | 13.47%286.87M | -12.22%260.03M | -38.09%303.36M | -10.14%295.51M | -27.48%252.81M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data